Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CICC Capital is the private equity investment fund operating and management platform of China International Capital Corporation. The company manages private equity and related investment funds and provides asset management, investment management, project investment, and investment advisory services. It is an investment institution rather than a drug developer, pharma company, or healthcare operating company. While it may participate in healthcare and biopharma funds as a financial sponsor or manager, its core business is financial services and private capital deployment across sectors. For biotech analyst purposes, this entity is best understood as a China-based private equity manager affiliated with CICC rather than a life sciences company with an R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CICC Capital Operations.